• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510600
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Neuropathy (1983); Pain (1994); Loss of Range of Motion (2032); Rash (2033); Swelling (2091); Inadequate Pain Relief (2388); Numbness (2415); Sleep Dysfunction (2517); Ambulation Difficulties (2544)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Multiple products were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Event Description
It was reported that on (b)(6) 2014, the patient underwent anterior lumbar interbody fusion surgery from vertebrae l5 to s1.Reportedly, rhbmp-2/acs was used in this surgery.The rhbmp-2 collagen sponge was placed outside a cage (i.E., in the disc space).Post-op, the patient suffered from increasing low back pain, left hip pain, and numbness and swelling in her left leg and foot.Patient continued to experience chronic back pain, with pain radiating across her hips and down her legs, constant swelling on her left side and left ankle, numbness in her left leg, and a rash on both legs.Patient also experienced bladder and bowel issues.Patient was unable to bend over, had difficulty sleeping due to extreme pain, cannot stand for long periods of time, and has difficulty walking.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on, (b)(6) 2014, the patient was pre-operatively diagnosed with diskogenic low back pain and underwent the following procedures: 1) anterior decompression at l4-5 and l5-s1 2) anterior lumbar fusion at l5-s1 with 14mm x 23mm cages, a large kit of rhbmp-2 and crushed cancellous allograft 3) disc replacement at l4-5 with prodisc-l (medium, 6 degree 10mm) with two sheets of rdx2 adhesion barrier.As per op-notes,¿ the anterior rectus fascia was incised and the rectus was reflected laterally.The retroperitoneal space was entered and a balfour retractor was placed.At this point, a large kit of rhbmp-2 was prepared per protocol and placed on the back table and allowed to cure.Surgeon began at l5-s 1.The middle sacral vessels overlying the disc were cauterized with a bipolar and ligated.The center of the disc was marked and surgeon turned attention to l4- 5.At l4-5, the sympathetic chain overlying the disc was cauterized with a bipolar and ligated.There was one large iliolumbar vein which was tied and double clipped and this allowed excellent exposure.Both discs were marked and the image intensifier was brought into position which confirmed our location in both ap and lateral planes.Surgeon began at l5-s 1.A block discectomy was performed over and above the simple block discectomy, surgeon identified a central disc herniation and annular tear and this was debrided until no further compression of the dura was noted.Surgeon then sized the space and elected to use 14 mm x 23 mm cages.Surgeon set the reamer at 29 mm, reamed and placed a bed of deep crushed cancellous allograft followed by two rhbmp-2 sponges, then one sponge per cage and one sponge lateral to each cage with additional crushed cancellous allograft.Pictures were obtained and showed good position of the devices and we turned our attention to l4-5.At l4-5 again a block discectomy was performed.¿ the patient tolerated the procedure well without any intraoperative complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key5740610
MDR Text Key47897451
Report Number1030489-2016-01844
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 03/23/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2015
Device Catalogue Number7510600
Device Lot NumberM111204AA8
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/05/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/13/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-